Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)

PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)

US Patent 10682336 · Granted Jun 16, 2020

Estimated economic value: $439,722,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2022
Methods of treating myelodysplastic syndromes with a combination therapy using l2021
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2019
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using imm2018
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using imm2018
Methods of treating myelodysplastic syndromes using lenalidomide2018
Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-2017
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione f2016
Methods for treating respiratory viral infection2016
Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-is2016
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))2016
Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroiso2015